EP Patent

EP3929179A1 — Anti-inflammatory compounds and methods for their manufacture

Assigned to Biohorm SL · Expires 2021-12-29 · 4y expired

What this patent protects

The present invention relates to an improved process for the preparation of anti-inflammatory compounds, such as N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-1,3-dioxoisoindol-4-yl]acetamide or a salt or solvate thereof and novel polymorphic forms thereof.

USPTO Abstract

The present invention relates to an improved process for the preparation of anti-inflammatory compounds, such as N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-1,3-dioxoisoindol-4-yl]acetamide or a salt or solvate thereof and novel polymorphic forms thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP3929179A1
Jurisdiction
EP
Classification
—
Expires
2021-12-29
Drug substance claim
No
Drug product claim
No
Assignee
Biohorm SL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.